Healthy high growth potential

Results

1532

Analysts expect these companies to experience strong growth in earnings over the next 3 years. They also meet criteria around being in an acceptable financial position.

1532 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv YieldIndustry
AXSM
US$216.27-2.1%94.6%US$11.2bUS$285.4214.661.1%n/aPharmaceuticals & Biotech
AAZ
UK£4.05-1.8%149.2%UK£463.1mUK£5.6835.525.9%0.7%Materials
FWRY
ج.م19.13-0.4%41.8%ج.م65.2bج.م22.4524.527.3%n/aDiversified Financials
GOLDR
NOK 7.52-3.6%n/aNOK 431.1mn/a19.686.0%n/aMaterials
WAYS
SEK 39.000.3%-1.0%SEK 342.0mSEK 58.00207.578.5%0%Tech
3036
NT$201.50-8.4%61.2%NT$259.2bNT$314.8610.528.9%3.9%Tech
456A
JP¥1,365.00-5.1%n/aJP¥128.8bn/a38.623.4%n/aRetail
MDGL
US$524.87-1.9%38.3%US$12.1bUS$678.069.463.7%n/aPharmaceuticals & Biotech
5038
JP¥2,139.00-0.2%-27.2%JP¥34.7bJP¥2,270.0026.920.3%1.0%Healthcare
4417
JP¥4,495.00-2.9%39.6%JP¥68.4bJP¥5,800.0042.026.4%1.1%Software
9218
JP¥765.001.6%-11.5%JP¥8.0bn/a33.828.9%1.3%Healthcare
SAUD3
R$13.730.2%6.8%R$40.1bR$17.6938.131.9%5.9%Healthcare
NVDA
US$225.013.4%23.6%US$5.5tUS$302.8334.122.9%0.4%Semiconductors
RHM
€1,214.006.3%-26.3%€56.9b€1,679.3846.830.5%0.9%Capital Goods
LITE
US$968.9019.1%714.3%US$82.1bUS$1,148.3028.5104.4%n/aTech
TGTX
US$49.280.2%77.7%US$6.9bUS$69.7115.821.3%n/aPharmaceuticals & Biotech
CRDO
US$282.8217.9%138.2%US$48.5bUS$281.13111.727.7%n/aSemiconductors
SPCX
US$146.235.4%n/aUS$1.8tUS$222.7383.656.5%n/aTelecom
MOD
US$216.7513.5%55.4%US$11.1bUS$310.2979.851.3%n/aCapital Goods
7769
NT$6,580.003.6%307.4%NT$1.2tNT$9,210.1867.947.9%1.0%Semiconductors
7685
JP¥3,200.001.3%85.2%JP¥210.2bJP¥4,866.6726.927.0%0.7%Retail
002384
CN¥213.8210.3%306.5%CN¥396.7bCN¥188.00191.073.1%0%Tech
6787
JP¥18,770.0011.0%132.6%JP¥496.9bJP¥28,400.0024.530.1%0.9%Tech
LPK
€15.05-3.5%87.4%€365.6m€22.753.7116.6%0%Tech
Page 1 of 43